Tissue Inhibitor of Metalloproteinases-3 Promoter Methylation is an Independent Prognostic Factor for Bladder Cancer
To access this article, please choose from the options below
Study received approval from The Johns Hopkins Hospital institutional review board.Supported by National Cancer Institute Grant U01-CA84986, Oncomethylome Sciences, SA, a Young Clinical Scientist Award from the Flight Attendant Medical Research Institute (MOH) and a Young Investigator Award from the International Association for the Study of Lung Cancer (MOH).
PII: S0022-5347(07)02490-1
doi:10.1016/j.juro.2007.09.019
© 2008 American Urological Association. Published by Elsevier Inc. All rights reserved.

